REAL-WORLD HEALTHCARE RESOURCE UTILISATION AMONG PATIENTS WITH CHRONIC HEART FAILURE- A CANADIAN ASSESSMENT
Author(s)
Petrella RJ1, Liu P2, Chiva-Razavi S3, Deschaseaux C4, Sagkriotis A4
1Lawson Health Research Institute, London, ON, Canada, 2University of Ottawa, Ottawa, ON, Canada, 3Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada, 4Novartis Pharma AG, Basel, Switzerland
OBJECTIVES: Limited evidence exists on the burden of chronic heart failure (CHF) in terms of reduced vs. preserved ejection fraction (HFrEF vs. HFpEF) and NYHA classification. This study aims to determine healthcare resource utilization associated with CHF, both for HFrEF (≥45%) and HFpEF (<40%) and according to NYHA class. METHODS: Retrospective analysis of a longitudinal population-based medical records database from southwestern Ontario was conducted. Records contain chart-abstracted information such as diagnosis, physician visits and consultation notes. Data of adult patients with CHF diagnosed between Jan 1st, 2005 and Sept 31st, 2012 with at least 1 year follow-up were included. Healthcare resources consumed by patients were identified in terms of hospitalizations, physician and emergency room visits and medical procedures. Data reported as mean values. RESULTS: Records of 8,983 patients were included: 39% with HFrEF, 49% with HFpEF and 12% with an ejection fraction between 40-45%. The median follow-up duration was 51.6 months. Most patients were in NYHA class II (30%) or class III (34%) followed by class I (22%) and class IV (14%). In comparison to the HFpEF cohort, total hospitalizations (3.0 vs. 4.2); including CHF hospitalizations (1.6 vs. 1.9), ER visits (2.1 vs. 3.1), GP visits (5.5 vs. 6.1), specialist visits (3.0 vs. 3.2), lab tests (5.8 vs. 7.7) and medical procedures (3.9 vs. 4.1) were numerically higher for the HFrEF cohort. Among patients in NYHA class II-IV (N=7006), hospitalizations (total: 4.5; CHF-related: 2.1) and lab tests (7.7) were numerically higher for class IV patients as was the frequency of GP visits (7.1) for class III patients. ER and specialist visits and medical procedures were similar across all NYHA classes. CONCLUSIONS: In a real-world Canadian setting, patients with HFrEF and those in NYHA class III-IV seem to experience greater resource use which is consistent with the existing literature.
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PCV98
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Cardiovascular Disorders